In this context, CD38 expression has been regarded as a potential marker of tumor proliferation; its expression fluctuates during the course of the disease and may be acquired or lost by CLL cells according to their proliferation status [38]. Here, CD38 is linked to B-cell chronic lymphocytic leukemia.